Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Dual PDK1/AKT inhibitor PHT-427 identified through PHuDock platform

May 10, 2010

Sirtuin expression linked to non-small cell lung cancer

May 10, 2010

Next-generation sequencing analysis identifies gene mutations affecting response to panitumumab

May 10, 2010

Antihypertensive efficacy of azilsartan medoxomil demonstrated in multiple studies

May 10, 2010

Cequent describes IND-enabling studies of RNAi drug for adenomatous polyposis

May 10, 2010

CNTO-2476 well tolerated in first-in-human study in patients with retinitis pigmentosa

May 7, 2010

Synergistic tolerogenic effects seen with RGI-2001 and anti-thymocyte globulin in vivo

May 7, 2010

New biomarkers of end-stage renal disease identified

May 7, 2010

Rivastigmine patch improves hepatic encephalopathy in clinical trial

May 7, 2010

Multiplex PI3K inhibitors suppress Ras-mutated tumors in vitro and in vivo

May 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...